The GIP receptor agonist component is thought to complement this by improving how the body breaks down sugar and fat
coordinating with your new provider about your prior dose, side effects, and goals minimizes transition risk
Both are once-weekly injections from Eli Lilly, but retatrutide adds a third hormone receptor (glucagon) on top of the GLP-1 and GIP receptors that tirzepatide already targets
The results are striking because the combination of these two drugs produces improvements in body composition we have never seen before in [] Past Due for Studying Maintenance Therapy in Obesity March 7, 2026 Health & Obesity, Scientific Meetings & Publications Neglect is a strong word
Couturier, J., Przybyla-Toscano, J., Roret, T., Didierjean, C
This medication is a tool, not a magic bullet : To achieve sustainable results and minimize side effects, Tirzepatide must be used within a medically supervised plan that includes gradual dosing, proper injection technique, and a comprehensive health strategy